Cargando…
Hemophilia A and B: molecular and clinical similarities and differences
Autores principales: | Castaman, Giancarlo, Matino, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717582/ https://www.ncbi.nlm.nih.gov/pubmed/31399527 http://dx.doi.org/10.3324/haematol.2019.221093 |
Ejemplares similares
-
Molecular Mechanisms of Inhibitor Development in Hemophilia
por: Tieu, Paul, et al.
Publicado: (2020) -
Hemophilia management: Huge impact of a tiny difference
por: Kloosterman, Fabienne, et al.
Publicado: (2020) -
Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
por: Linari, Silvia, et al.
Publicado: (2020) -
Managing Relevant Clinical Conditions of Hemophilia A/B Patients
por: Morfini, Massimo, et al.
Publicado: (2023) -
The Arrival of Gene Therapy for Patients with Hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2022)